股票 › QURE
uniQure基因治疗 QURE
美股市值排名 #2937
$21.70 +$0.69 (+3.28%)
休市 · Nov 7, 10:00 pm ET · 最新盘后价 $22.00 +1.38%
开盘$21.25
昨收$21.01
当日区间$21.10 – $21.93
成交量1.17M
市值$1.52B
市盈率（TTM）–
股息率–
QURE 相关新闻
匹配 uniQure NV 或代码 QURE 的头条新闻，按最新排序。
- A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $31 to $80
- Analysts' Top Healthcare Picks: UniQure (QURE), Alumis Inc. (ALMS)
- Wells Fargo Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $75 正面
- TD Cowen Maintains UniQure NV(QURE.US) With Buy Rating
- Stifel Maintains UniQure NV(QURE.US) With Buy Rating
- William Blair Upgrades UniQure NV(QURE.US) to Buy Rating 正面
- Stifel Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $71
- H.C. Wainwright Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $80
- Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Fortrea Holdings Inc. (FTRE) and UniQure (QURE)
- A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $46 to $68
- Goldman Sachs Maintains UniQure NV(QURE.US) With Hold Rating, Maintains Target Price $46
- H.C. Wainwright Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $80 正面
- Mizuho Securities Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $68 正面
- Barclays Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $65
- Stifel Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $71 正面
暂无评论——快来第一个聊聊 QURE。
登录后参与讨论。